KAMEKO OSHIRO: Open Payments
NPI 1225780059 · LAGUNA HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,365 in 92 payments from 29 companies in 2025. Trend: 2023 $2,429 · 2024 $2,616 · 2025 $2,365
Food & beverage: $2,365
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $235 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $227 |
| Insulet Corporation | 5 | $177 |
| Amgen Inc. | 4 | $175 |
| Lilly USA, LLC | 11 | $165 |
| SANOFI-AVENTIS U.S. LLC | 6 | $153 |
| Travere Therapeutics, Inc. | 1 | $149 |
| Mallinckrodt Hospital Products Inc. | 7 | $143 |
| Corcept Therapeutics | 5 | $141 |
| Mannkind Corporation | 6 | $96 |
Products named: JARDIANCE, Omnipod, TZIELD, UBRELVY, REPATHA, ACTHAR, Korlym, MOUNJARO.
Industry payments across CA — which companies pay providers there.
